- Home
- LEXX vs AACG Comparison
LEXX vs AACG Comparison
Compare LEXX & AACG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- AACG
- Stock Information
- Founded
- LEXX 2004
- AACG 1999
- Country
- LEXX Canada
- AACG China
- Employees
- LEXX N/A
- AACG N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- AACG Other Consumer Services
- Sector
- LEXX Health Care
- AACG Real Estate
- Exchange
- LEXX Nasdaq
- AACG Nasdaq
- Market Cap
- LEXX 38.9M
- AACG 31.9M
- IPO Year
- LEXX N/A
- AACG N/A
- Fundamental
- Price
- LEXX $2.23
- AACG $0.84
- Analyst Decision
- LEXX Strong Buy
- AACG
- Analyst Count
- LEXX 2
- AACG 0
- Target Price
- LEXX $11.00
- AACG N/A
- AVG Volume (30 Days)
- LEXX 202.7K
- AACG 24.5K
- Earning Date
- LEXX 01-10-2025
- AACG 11-07-2024
- Dividend Yield
- LEXX N/A
- AACG N/A
- EPS Growth
- LEXX N/A
- AACG N/A
- EPS
- LEXX N/A
- AACG N/A
- Revenue
- LEXX $464,278.00
- AACG $35,747,843.00
- Revenue This Year
- LEXX $20.39
- AACG N/A
- Revenue Next Year
- LEXX $113.25
- AACG N/A
- P/E Ratio
- LEXX N/A
- AACG N/A
- Revenue Growth
- LEXX 105.24
- AACG 15.80
- 52 Week Low
- LEXX $1.20
- AACG $0.50
- 52 Week High
- LEXX $6.85
- AACG $1.65
- Technical
- Relative Strength Index (RSI)
- LEXX 47.23
- AACG 36.73
- Support Level
- LEXX $2.00
- AACG $0.70
- Resistance Level
- LEXX $2.54
- AACG $0.92
- Average True Range (ATR)
- LEXX 0.24
- AACG 0.06
- MACD
- LEXX -0.00
- AACG -0.01
- Stochastic Oscillator
- LEXX 27.06
- AACG 48.28
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.
About AACG ATA Creativity Global
ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments are Overseas art study services, Other educational services and K-12 education assessment and other services. Majority of its revenue comes from Overseas art study services.